ASP Isotopes Inc. Common Stock
ASPIASP Isotopes Inc. (ASPI) specializes in the production and sale of medical and industrial isotopes, with a focus on advanced nuclear materials used in diagnostic imaging, cancer treatment, and other high-tech applications. The company aims to develop innovative isotope solutions to address growing demand in healthcare and industrial markets.
Company News
ASP Isotopes announced that it and its subsidiary Quantum Leap Energy (QLE) have entered into exchange agreements with certain convertible note holders. Approximately $109.2 million in QLE Notes will be exchanged for roughly 23.2 million shares of ASPI common stock, reducing QLE's outstanding convertible notes by approximately 50% from $219.8 mil...
Grabar Law Office is investigating securities fraud claims against four companies: ASP Isotopes for allegedly making false statements about uranium enrichment technology; Integer Holdings for overstating competitive position and concealing sales deterioration; Molina Healthcare for failing to disclose adverse medical cost trends; and Soleno Thera...
Grabar Law Office is investigating securities fraud claims against four companies: ASP Isotopes for allegedly making false statements about uranium enrichment technology; Integer Holdings for overstating competitive position and concealing sales deterioration; Soleno Therapeutics for misrepresenting safety profile of drug candidate DCCR/VYKAT XR;...
Grabar Law Office is investigating securities fraud claims against four companies: ASP Isotopes (ASPI) for allegedly making false statements about uranium enrichment technology; Camping World (CWH) for misrepresenting inventory management and financial outlook; EOS Energy (EOSE) for failing to disclose production challenges and operational issues...
Shorepower Technologies (OTC: SPEV) has entered into a merger agreement with Aeternum Health LLC, marking a strategic pivot from transportation electrification infrastructure to longevity and health optimization technologies. The merger involves issuing 51% common stock ownership to Aeternum Health's sole member, 2 million Series B Preferred Shar...
